Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis

Michael J. Jarzynka, Ping Gou, Ifat Bar-Joseph, Bo Hu, Shi Yuan Cheng*

*Corresponding author for this work

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Angiogenesis is required for lung cancer growth, which is mediated by various growth factors such as vascular endothelial growth factor (VEGF). Increases in VEGF and angiogenesis have been correlated with poor prognosis and survival in patients with lung cancer. In addition, recent reports show that estradiol and nicotine play important roles in lung tumor initiation and progression. In this report, we demonstrate that estradiol and nicotine exposure enhances the growth of A549 bronchioloalveolar carcinoma xenografts in mice through the stimulation of cell proliferation, VEGF secretion and angiogenesis. We detect a four-fold increase in microvascular density in tumors from mice exposed to estradiol and nicotine compared to control tumors resulting in an increase in tumor growth. Intriguingly, the effects on angiogenesis and tumor growth by the combination of agents were additive when compared to either agent alone. Furthermore, estradiol promotes VEGF secretion from various non-small cell lung carcinoma (NSCLC) cells and this effect is augmented by nicotine in a tumor xenograft model. These results indicate that aside from their roles in promoting cell proliferation, estradiol and nicotine appear to have additive effects on the induction of angiogenesis through the stimulation of VEGF secretion during NSCLC progression.

Original languageEnglish (US)
Pages (from-to)337-344
Number of pages8
JournalInternational Journal of Oncology
Volume28
Issue number2
StatePublished - Feb 1 2006

Fingerprint

Bronchiolo-Alveolar Adenocarcinoma
Nicotine
Heterografts
Estradiol
Vascular Endothelial Growth Factor A
Growth
Neoplasms
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Cell Proliferation
Intercellular Signaling Peptides and Proteins
Lung
Survival

Keywords

  • Angiogenesis
  • Estradiol
  • Lung tumor
  • Nicotine
  • VEGF

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{4d43893f120f423ba2d86efc2db1ff7d,
title = "Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis",
abstract = "Angiogenesis is required for lung cancer growth, which is mediated by various growth factors such as vascular endothelial growth factor (VEGF). Increases in VEGF and angiogenesis have been correlated with poor prognosis and survival in patients with lung cancer. In addition, recent reports show that estradiol and nicotine play important roles in lung tumor initiation and progression. In this report, we demonstrate that estradiol and nicotine exposure enhances the growth of A549 bronchioloalveolar carcinoma xenografts in mice through the stimulation of cell proliferation, VEGF secretion and angiogenesis. We detect a four-fold increase in microvascular density in tumors from mice exposed to estradiol and nicotine compared to control tumors resulting in an increase in tumor growth. Intriguingly, the effects on angiogenesis and tumor growth by the combination of agents were additive when compared to either agent alone. Furthermore, estradiol promotes VEGF secretion from various non-small cell lung carcinoma (NSCLC) cells and this effect is augmented by nicotine in a tumor xenograft model. These results indicate that aside from their roles in promoting cell proliferation, estradiol and nicotine appear to have additive effects on the induction of angiogenesis through the stimulation of VEGF secretion during NSCLC progression.",
keywords = "Angiogenesis, Estradiol, Lung tumor, Nicotine, VEGF",
author = "Jarzynka, {Michael J.} and Ping Gou and Ifat Bar-Joseph and Bo Hu and Cheng, {Shi Yuan}",
year = "2006",
month = "2",
day = "1",
language = "English (US)",
volume = "28",
pages = "337--344",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "2",

}

Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis. / Jarzynka, Michael J.; Gou, Ping; Bar-Joseph, Ifat; Hu, Bo; Cheng, Shi Yuan.

In: International Journal of Oncology, Vol. 28, No. 2, 01.02.2006, p. 337-344.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis

AU - Jarzynka, Michael J.

AU - Gou, Ping

AU - Bar-Joseph, Ifat

AU - Hu, Bo

AU - Cheng, Shi Yuan

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Angiogenesis is required for lung cancer growth, which is mediated by various growth factors such as vascular endothelial growth factor (VEGF). Increases in VEGF and angiogenesis have been correlated with poor prognosis and survival in patients with lung cancer. In addition, recent reports show that estradiol and nicotine play important roles in lung tumor initiation and progression. In this report, we demonstrate that estradiol and nicotine exposure enhances the growth of A549 bronchioloalveolar carcinoma xenografts in mice through the stimulation of cell proliferation, VEGF secretion and angiogenesis. We detect a four-fold increase in microvascular density in tumors from mice exposed to estradiol and nicotine compared to control tumors resulting in an increase in tumor growth. Intriguingly, the effects on angiogenesis and tumor growth by the combination of agents were additive when compared to either agent alone. Furthermore, estradiol promotes VEGF secretion from various non-small cell lung carcinoma (NSCLC) cells and this effect is augmented by nicotine in a tumor xenograft model. These results indicate that aside from their roles in promoting cell proliferation, estradiol and nicotine appear to have additive effects on the induction of angiogenesis through the stimulation of VEGF secretion during NSCLC progression.

AB - Angiogenesis is required for lung cancer growth, which is mediated by various growth factors such as vascular endothelial growth factor (VEGF). Increases in VEGF and angiogenesis have been correlated with poor prognosis and survival in patients with lung cancer. In addition, recent reports show that estradiol and nicotine play important roles in lung tumor initiation and progression. In this report, we demonstrate that estradiol and nicotine exposure enhances the growth of A549 bronchioloalveolar carcinoma xenografts in mice through the stimulation of cell proliferation, VEGF secretion and angiogenesis. We detect a four-fold increase in microvascular density in tumors from mice exposed to estradiol and nicotine compared to control tumors resulting in an increase in tumor growth. Intriguingly, the effects on angiogenesis and tumor growth by the combination of agents were additive when compared to either agent alone. Furthermore, estradiol promotes VEGF secretion from various non-small cell lung carcinoma (NSCLC) cells and this effect is augmented by nicotine in a tumor xenograft model. These results indicate that aside from their roles in promoting cell proliferation, estradiol and nicotine appear to have additive effects on the induction of angiogenesis through the stimulation of VEGF secretion during NSCLC progression.

KW - Angiogenesis

KW - Estradiol

KW - Lung tumor

KW - Nicotine

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=39049182962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049182962&partnerID=8YFLogxK

M3 - Article

C2 - 16391787

AN - SCOPUS:39049182962

VL - 28

SP - 337

EP - 344

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 2

ER -